FLUZONE HIGH-DOSE Rx
Generic Name and Formulations:
Trivalent inactivated "split virus" influenza vaccine (Types A and B); 0.5mL dose contains a total of 180mcg of influenza virus hemagglutinin; formulation changes annually; susp for IM inj.
Sanofi Pasteur, Inc.
Indications for FLUZONE HIGH-DOSE:
Influenza immunization for patients ≥65yrs of age.
<65yrs: use Fluzone or Fluzone Intradermal. ≥65yrs: One dose per year. 0.5mL IM in deltoid muscle.
Use Fluzone IM.
Allergy to egg proteins. Life-threatening reaction to any previous flu vaccine.
Use current formulation only. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Immunosuppressed. Have epinephrine inj (1:1000) available. Pregnancy (Cat.C for IM and High-Dose; Cat.B for Intradermal, Intradermal Quadrivalent). Nursing mothers.
Immunosuppressants: may get suboptimal response.
Local reactions (eg, pain, tenderness, swelling, erythema), malaise, headache, myalgia, irritability.
Fluzone, Fluzone Quadrivalent prefilled syringe (0.25mL, 0.5mL)—10; Single-dose vial (0.5mL)—10; Fluzone multi-dose vial (5mL)—1 (contains thimerosal); Fluzone High-Dose prefilled syringe (0.5mL)—10; Fluzone Intradermal, Fluzone Intradermal Quadrivalent single-dose prefilled microinjection system (0.1mL)—10
Endocrinology Advisor Articles
- Triple-Goal Achievement Reduces Risk for Complications in Type 2 Diabetes
- Inverse Association Between Serum 25(OH)D Levels and Risk for Diabetes
- ADA Issues White Paper Addressing Escalating Cost of Insulin
- Neprilysin Inhibition May Reduce Renal Function Deterioration in Comorbid T2D and Chronic Heart Failure
- Serum Chemerin May Predict Risk for Spontaneous Abortion in Women With PCOS
- Diabetes Treatments
- Incretins, Thiazolidinediones Associated With Better Glycemic Control in T2D
- No Link Between HbA1c Levels and Wound Healing in Patients With Diabetic Foot Ulcers
- Risk for Fetal Loss Early in Pregnancy Not Greater With Noninsulin vs Insulin Therapy
- Use of In-Hospital Continuous Subcutaneous Insulin Infusion: A Consensus Statement
- Effects of Gender on Clinical Outcomes in Empagliflozin-Treated Type 2 Diabetes
- Effect of Acetyl-L-Carnitine on Blood Pressure in Type 2 Diabetes
- PAH Risk, Mortality Increased by Disturbances in Male Sex Hormones
- Perioperative Cardiovascular Events More Common in Diabetes
- Individuals With Type 1 Diabetes See Improvement With Continuous Glucose Monitoring